drugset / Trial / NCT00562731
Open-Label Study of ARD-0403 in Testosterone Deficient Men
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Male hypogonadism, a disorder associated with testosterone deficiency, is frequently seen in clinical practice and has significant effects on patient well-being. The purpose of this study is to investigate the efficacy and safety of ARD-0403 as a testosterone replacement therapy in testosterone deficient men.
Timeline
- Start
- 2007-10
- Primary completion
- —
- Completion
- 2008-06
Outcome
Outcome not reported
Stopped (Business): “Company strategic decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ARD-0403 | Unknown | — | Other |